Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity.
The strong fibrin affinity of recombinant tissue plasminogen activator (rt-PA) theoretically obviates continuous infusion or replacement of t-PA after direct intrathrombic injection. This hypothesis led the authors to evaluate single daily catheter-directed injection of rt-PA as a thrombolytic treatment for acute deep vein thrombosis of the lower extremity. Once-daily injection of rt-PA was performed in large thrombosed veins (popliteal or larger) with use of pulse-spray catheters and in small thrombosed veins in patients' calves with use of 3-4-F coaxial catheters. Patients received only full systemic anticoagulation on his/her patient care unit. This dosing regimen has been tested in 10 patients (12 legs) with a maximum dose of 50 mg per leg per day. Extensive thrombolysis was achieved in nine patients and partial thrombolysis was achieved in one patient, at an average total dose of 106 mg of rt-PA per leg. Minor bleeding was seen in three patients and no transfusions were needed. Our technique and the rationale for this pilot study is the focus of this article.
Chang
R
R
Department of Diagnostic Radiology, National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Cannon
R O
RO
Chen
C C
CC
Doppman
J L
JL
Shawker
T H
TH
Mayo
D J
DJ
Wood
B
B
Horne
M K
MK
D002406:Catheterization, Peripheral; D004334:Drug Administration Schedule; D006801:Humans; D007275:Injections, Intravenous; D007866:Leg / Q000098:blood supply*; D010960:Plasminogen Activators / Q000008:administration & dosage* / Q000627:therapeutic use; D011152:Popliteal Vein; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy*
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator